Chimeric Antigen Receptors targeting FGFR4 and/or CD276 with CD28 HTM and CSD for childhood rhabdomyosarcoma
Technology
E-020-2024
Patent ID
E-020-2024-0-US-01
Country
US
Application Type
Patent Status
Expired
Patent Number
Publication Number
Application Number
63/634,330
IC
NCI
Date Filed
Date Issued
Patent PDF